CRBU: Caribou Biosciences Inc Company Profile & Statistics

About

Caribou Biosciences Inc. is a clinical-stage CRISPR genome-editing biopharmaceutical company. It involved in developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for the treatment of both hematologic malignancies and solid tumors. Caribou Biosciences Inc. is based in BERKELEY, Calif.

Info & Links

CEO

Rachel E. Haurwitz

Headquarters

2929 7TH STREET, SUITE 105
BERKELEY, CA 94710, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

158

Caribou Biosciences Inc Statistics

Valuation Measures

Market Capitalization²

161.63M

Enterprise Value

129.66M

Enterprise Value/EBITDA(ttm)

-0.79

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

15.07

Price to Book(mrq)

0.61

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-1290.81%

Profit Margin(ttm)

-1367.31%

Return on Equity(ttm)

-45.46%

Return on Invested Capital(ttm)

-45.85%

Return on Assets(ttm)

-38.07%

Income Statement

Revenue(ttm)

11.47M

Revenue Per Share(ttm)

0.13

Gross Profit(ttm)

11.47M

EBITDA(ttm)³

-163.79M

Net Income Available to Common(ttm)

-148.12M

Diluted EPS(ttm)

-1.65

Share Statistics

Beta (5Y Monthly)

2.27

52-Week Change

-69.28%

S&P 500 52-Week Change

25.80%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

90.55M

Dividend Yield

0.00%

Float⁴

81.95M

% Held by Insiders

9.50%

% Held by Institutions

77.51%

Balance Sheet

Total Cash(mrq)

228.18M

Total Cash Per Share(mrq)

2.52

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.38%

Quick Ratio(mrq)

7.38%

Book Value Per Share(mrq)

3.11

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.14

Free Cash Flow(ytd)

-107.09M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CRBU

Caribou Biosciences Inc

Caribou Biosciences Inc Profile